Lower cardiovascular mortality with atorvastatin and rosuvastatin vs simvastatin: Data from "moderate-intensity" statin users in an observational registry on chronic heart failure (Daunia Heart Failure Registry)

Int J Cardiol. 2015 Sep 1:194:23-7. doi: 10.1016/j.ijcard.2015.05.041. Epub 2015 May 9.

Authors

Natale Daniele Brunetti¹, Michele Correale², Antonio Totaro², Armando Ferraretti², Ilenia Monaco², Tommaso Passero², Luisa De Gennaro³, Matteo Di Biase²

Affiliations

¹ Cardiology Department, University of Foggia, Foggia, Italy. Electronic address: [email protected].
² Cardiology Department, University of Foggia, Foggia, Italy.
³ Cardiology Department, University of Foggia, Foggia, Italy; Department of Cardiology, Ospedale San Paolo, Bari, Italy.

PMID: 26005803
DOI: 10.1016/j.ijcard.2015.05.041

No abstract available

Keywords: Atorvastatin; Chronic heart failure; Moderate-intensity; Rosuvastatin; Simvastatin; Statins.

Publication types

Letter

MeSH terms

Aged
Atorvastatin / administration & dosage
Female
Heart Failure / drug therapy*
Heart Failure / mortality*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
Italy / epidemiology
Male
Observational Studies as Topic
Randomized Controlled Trials as Topic
Registries
Rosuvastatin Calcium / administration & dosage
Simvastatin / administration & dosage
Treatment Outcome
Ventricular Function, Left / drug effects

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Rosuvastatin Calcium
Atorvastatin
Simvastatin